Targeting PIK3CA-mutant advanced breast cancer in the clinical setting.

Thumbnail
View/Open
Publication Date
2017-07
ICR Author
Author
Chopra, N
Turner, NC
Type
Journal Article
Metadata
Show full item record
URL
https://repository.icr.ac.uk/handle/internal/817
Collections
Licenseref URL
http://www.rioxx.net/licenses/all-rights-reserved
Funder
The Institute of Cancer Research (Grant ID: Unspecified)
Version of record
Subject
Humans
Breast Neoplasms
Mutation
Phosphatidylinositol 3-Kinases
Class I Phosphatidylinositol 3-Kinases
Research team
Molecular Oncology
Language
eng
Date accepted
2017-05-11
License start date
2017-07
Citation
The Lancet. Oncology, 2017, 18 (7), pp. 842 - 843